791: a randomized trial of vedolizumab dose optimization in patients with moderate to severe ulcerative colitis who have early nonresponse and high drug clearance: the enterpret trial

GASTROENTEROLOGY(2022)

引用 5|浏览1
暂无评分
关键词
vedolizumab dose optimization,severe ulcerative colitis,ulcerative colitis,high drug clearance
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要